Home/Filings/4/0001927362-25-000017
4//SEC Filing

EVANS LAWRENCE R 4

Accession 0001927362-25-000017

CIK 0000277638other

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 10:55 AM ET

Size

38.0 KB

Accession

0001927362-25-000017

Insider Transaction Report

Form 4
Period: 2025-08-29
EVANS LAWRENCE R
EVP & GM, Surgery Company
Transactions
  • Exercise/Conversion

    Common Stock

    2025-08-29$8.18/sh+4,000$32,720214,599 total
  • Exercise/Conversion

    Common Stock

    2025-08-29$10.55/sh+3,630$38,297224,629 total
  • Exercise/Conversion

    Common Stock

    2025-08-29$8.18/sh+8,400$68,712237,029 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2025-08-294,0000 total
    Exercise: $8.18From: 2017-06-28Exp: 2026-06-28Common Stock (4,000 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2025-08-293,6300 total
    Exercise: $10.55From: 2020-06-12Exp: 2029-06-12Common Stock (3,630 underlying)
  • Exercise/Conversion

    Common Stock

    2025-08-29$8.80/sh+3,000$26,400217,599 total
  • Exercise/Conversion

    Common Stock

    2025-08-29$12.10/sh+4,000$48,400228,629 total
  • Sale

    Common Stock

    2025-08-29$25.50/sh2,695$68,723234,334 total
  • Exercise/Conversion

    Common Stock

    2025-08-29$8.80/sh+4,400$38,720238,734 total
  • Exercise/Conversion

    Common Stock

    2025-08-29$9.55/sh+8,638$82,493245,854 total
  • Sale

    Common Stock

    2025-08-29$25.50/sh4,838$123,369237,783 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2025-08-293,0000 total
    Exercise: $8.80From: 2018-06-23Exp: 2027-06-23Common Stock (3,000 underlying)
  • Exercise/Conversion

    Stock Appreciation Rights (2017)

    2025-08-294,4000 total
    Exercise: $8.80From: 2018-03-03Exp: 2027-03-03Common Stock (4,400 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2025-08-294,0000 total
    Exercise: $12.10From: 2021-06-17Exp: 2030-06-17Common Stock (4,000 underlying)
  • Exercise/Conversion

    Stock Appreciation Rights (2016)

    2025-08-298,4000 total
    Exercise: $8.18From: 2017-03-04Exp: 2026-03-04Common Stock (8,400 underlying)
  • Exercise/Conversion

    Stock Appreciation Rights (2018)

    2025-08-298,6380 total
    Exercise: $9.55From: 2019-03-09Exp: 2028-03-09Common Stock (8,638 underlying)
  • Exercise/Conversion

    Common Stock

    2025-08-29$9.55/sh+3,400$32,470220,999 total
  • Sale

    Common Stock

    2025-08-29$25.50/sh1,518$38,709237,216 total
  • Sale

    Common Stock

    2025-08-29$25.50/sh3,233$82,442242,621 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2025-08-293,4000 total
    Exercise: $9.55From: 2019-06-28Exp: 2028-06-28Common Stock (3,400 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    37,536.272
Footnotes (8)
  • [F1]Exercise of SARs upon retirement.
  • [F2]Payment of taxes in connection with SARs pay-out.
  • [F3]This total reflects routine accumulation of 37,536.2717 common shares acquired through the Company's 401(K) benefit plan as of August 29, 2025, based on internal records.
  • [F4]These options become exercisable in 20% installments on each anniversary of the grant date beginning June 28, 2017.
  • [F5]These options become exercisable in 20% installments on each anniversary of the grant date beginning June 23, 2018.
  • [F6]These options become exercisable in 20% installments on each anniversary of the grant date beginning June 28, 2019.
  • [F7]These options become exercisable in 20% installments on each anniversary of the grant date beginning June 12, 2020.
  • [F8]These options become exercisable in 20% installments on each anniversary of the grant date beginning June 17, 2021.

Issuer

DAVEY TREE EXPERT CO

CIK 0000277638

Entity typeother

Related Parties

1
  • filerCIK 0001927362

Filing Metadata

Form type
4
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 10:55 AM ET
Size
38.0 KB